Showing results (91-100 of 447) with videos related to
Sort By:
Pageof 45
Cancer Science|August 25, 2021
Real-world safety of nivolumab in patients with non-small-cell lung cancer in Japan: Postmarketing surveillanceNobuyuki Yamamoto, Yoichi Nakanishi, Akihiko Gemma, et al.Anticancer Research|March 14, 2013
Safety and efficacy of platinum agents plus etoposide for patients with small cell lung cancer with interstitial lung diseaseTatsuya Yoshida, Kiyotaka Yoh, Koichi Goto, et al.Japanese Journal of Clinical Oncology|March 19, 2019
Cryobiopsy during flex-rigid pleuroscopy: an emerging alternative biopsy method in malignant pleural mesothelioma. A comparative study of pathologyToshiyuki Nakai, Yuji Matsumoto, Shinji Sasada, et al.Translational Lung Cancer Research|December 13, 2023
Identifying factors causing failure of nodal staging by endobronchial ultrasound-guided transbronchial needle aspiration in non-small cell lung cancerClara So, Yuji Matsumoto, Tatsuya Imabayashi, et al.Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Switch maintenance chemotherapy using S-1 with or without bevacizumab in patients with advanced non-small cell lung cancer: a phase II studySeiji Niho, Yuichiro Ohe, Hironobu Ohmatsu, et al.Cancer Science|June 29, 2007
Bodyweight change during the first 5 days of chemotherapy as an indicator of cisplatin renal toxicityIkuo Sekine, Kazuhiko Yamada, Hiroshi Nokihara, et al.Journal of Cancer Research and Clinical Oncology|May 13, 2015
Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lungMasahiro Morise, Tomoyuki Hishida, Akiko Takahashi, et al.The Tohoku Journal of Experimental Medicine|September 6, 2007
Problems with registration-directed clinical trials for lung cancer in JapanIkuo Sekine, Hiroshi Nokihara, Noboru Yamamoto, et al.British Journal of Cancer|September 21, 2023
Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancerMasayuki Shirasawa, Tatsuya Yoshida, Kouya Shiraishi, et al.Cancer Science|February 19, 2019
Safety and effectiveness of alectinib in a real-world surveillance study in patients with ALK-positive non-small-cell lung cancer in JapanNoriyuki Masuda, Yuichiro Ohe, Akihiko Gemma, et al.Pageof 45